- Report
- November 2025
- 450 Pages
Global
From €3605EUR$3,995USD£3,132GBP
- Report
- October 2025
- 1400 Pages
Global
From €4508EUR$4,995USD£3,916GBP
- Report
- January 2026
- 165 Pages
Global
From €4331EUR$4,799USD£3,763GBP
- Report
- February 2026
- 255 Pages
Global
From €3745EUR$4,150USD£3,254GBP
- Report
- February 2026
- 229 Pages
Global
From €4196EUR$4,650USD£3,646GBP
- Report
- November 2025
- 150 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- July 2025
- 237 Pages
Global
From €2256EUR$2,500USD£1,960GBP
- Report
- January 2026
Global
From €4422EUR$4,900USD£3,842GBP
- Report
- April 2025
Global
From €4422EUR$4,900USD£3,842GBP
- Report
- May 2025
- 137 Pages
Global
From €3609EUR$3,999USD£3,135GBP
- Report
- January 2026
- 197 Pages
Global
From €3199EUR$3,545USD£2,780GBP
€3555EUR$3,939USD£3,088GBP
- Report
- January 2026
- 196 Pages
Global
From €3199EUR$3,545USD£2,780GBP
€3555EUR$3,939USD£3,088GBP
- Report
- January 2026
- 190 Pages
Global
From €3199EUR$3,545USD£2,780GBP
€3555EUR$3,939USD£3,088GBP
- Report
- January 2026
- 192 Pages
Global
From €3199EUR$3,545USD£2,780GBP
€3555EUR$3,939USD£3,088GBP
- Report
- August 2025
- 180 Pages
Global
From €3199EUR$3,545USD£2,780GBP
€3555EUR$3,939USD£3,088GBP
- Report
- December 2025
- 210 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- October 2025
- 120 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- May 2025
- 130 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- August 2025
Global
From €4422EUR$4,900USD£3,842GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more